Anika Therapeutics (ANIK) Non-cash Items (2012 - 2026)

Anika Therapeutics (ANIK) has 13 years of Non-cash Items data on file, last reported at $1.7 million in Q1 2026.

• Non-cash Items for Q1 2026 came in at $1.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (changed N/A YoY), and the FY2025 annual result was $1000.0, changed N/A from the prior year.
• Non-cash Items grew to $1.7 million in Q1 2026 per ANIK's latest filing, from $1000.0 in the prior quarter.
• Over five years, Non-cash Items peaked at $1.7 million in Q1 2026 and troughed at $1000.0 in Q2 2025.
• A 5-year average of $331928.6 and a median of $157500.0 in 2023 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2023 and 2025: Non-cash Items surged 6922.22% in 2023, then sank 99.67% in 2025.
• A 5-year view of Non-cash Items shows it stood at $1.0 million in 2022, then plunged by 87.9% to $127000.0 in 2023, then jumped by 95.28% to $248000.0 in 2024, then plunged by 99.6% to $1000.0 in 2025, then surged by 166500.0% to $1.7 million in 2026.
• Business Quant data shows ANIK's Non-cash Items at $1.7 million in Q1 2026, $1000.0 in Q4 2025, and $1000.0 in Q2 2025.